EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 12 (2026) SICOT-J, 12 (2026) 13 References
Open Access
Review
Issue
SICOT-J
Volume 12, 2026
Article Number 13
Number of page(s) 9
Section Hip
DOI https://doi.org/10.1051/sicotj/2026008
Published online 08 April 2026
  1. Piel FB, Patil AP, Howes RE, et al. (2010) Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 1, 104. [Google Scholar]
  2. Osunkwo I, Andemariam B, Minniti CP, et al. (2021) Impact of sickle cell disease on patients’ daily lives, symptoms reported, and disease management strategies: results from the international sickle cell world assessment survey (SWAY). Am J Hematol 96(4), 404–417. [Google Scholar]
  3. Yaya I, Pourageaud A, Derbez B, et al. (2024) Predictors of health-related quality of life in a large cohort of adult patients living with sickle cell disease in France: the DREPAtient study. Front Public Health 12, 1374805. [Google Scholar]
  4. Williams TN (2016) Sickle cell disease in sub-Saharan Africa, Hematol Oncol Clin North Am 30(2), 343–358. [Google Scholar]
  5. Shet AS, Thein SL (2019) A growing population of older adults with sickle cell disease. Clin Geriatr Med 35(3), 349–367. [Google Scholar]
  6. Mahadeo KM, Oyeku S, Taragin B, et al. (2011) Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease. Am J Hematol 86(9), 806–808. [Google Scholar]
  7. Balogun RA, Obalum DC, Giwa SO, Adekoya-Cole TO, Ogo CN, Enweluzo GO (2010) Spectrum of musculoskeletal disorders in sickle cell disease in Lagos. Nigeria, J Orthop Surg 8(5), 2. [Google Scholar]
  8. GBD (2021) sickle cell disease collaborators (2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the global burden of disease study 2021. Lancet Haematol 10(8), e585–e599. [Google Scholar]
  9. Sadat-Ali M, Al-Omran AS, AlTabash K, Acharya S, Hegazi TM, Al Muhaish MI (2022) The clinical and radiological effectiveness of autologous bone marrow-derived osteoblasts (ABMDO) in the management of avascular necrosis of femoral head (ANFH) in sickle cell disease (SCD). J Exp Orthop 9(1), 18. [Google Scholar]
  10. Grimbly C, Escagedo PD, Jaremko JL, et al. (2022) Sickle cell bone disease and response to intravenous bisphosphonates in children. Osteoporos Int J 33(11), 2397–2408. [Google Scholar]
  11. Casale M, Toro G, Porcelli F, et al. (2025) Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: results from a multicentre study. Br J Haematol 206(1), 310–319. [Google Scholar]
  12. Mallet C, Abitan A, Vidal C, et al. (2018) Management of osteonecrosis of the femoral head in children with sickle cell disease: results of conservative and operative treatments at skeletal maturity. J Child Orthop 12(1), 47–54. [Google Scholar]
  13. Adigwe OP, Onoja SO, Onavbavba G (2023) A critical review of sickle cell disease burden and challenges in sub-Saharan Africa, J Blood Med 14, 367–376. [Google Scholar]
  14. Peters MDJ, Marnie C, Tricco AC, et al. (2020) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 18(10), 2119–2126. [CrossRef] [PubMed] [Google Scholar]
  15. Iwegbu CG, Fleming AF (1985) Avascular necrosis of the femoral head in sickle-cell disease. A series from the Guinea Savannah of Nigeria. J Bone Joint Surg Br 67(1), 29–32. [Google Scholar]
  16. Ben Dridi MF, Oumaya A, Gastli H, et al. (1987) Radiological abnormalities of the skeleton in patients with sickle-cell anemia. A study of 222 cases in Tunisia. Pediatr Radiol 17(4), 296–302. [Google Scholar]
  17. Ugbeye ME, Lawal W, Ayodabo O, Dim EM, Adegoke S (2020) Total hip arthroplasty in sickle cell disease patients in a developing country. Niger J Clin Pract 23(10), 1426–1430. [Google Scholar]
  18. Katchy AU, Anyaehie UE, Nwadinigwe CU, Eyichukwu GO (2018) Total hip replacement in sickle cell disorder: a preliminary report of challenges and early outcome of 21 consecutive patients. Niger J Clin Pract 21(4), 492–495. [Google Scholar]
  19. Ekere AU, Eze CB, Ebirim LN (2008) A report of two cases of uncemented total hip replacement in patients with sickle cell disease. Niger J Clin Pract 11(3), 257–259. [Google Scholar]
  20. Ebong WW, Kolawole TM (1986) Aseptic necrosis of the femoral head in sickle-cell disease. Br J Rheumatol 25(1), 34–39. [Google Scholar]
  21. Ugbeye ME, Alatishe KA, Okezie C (2024) Bilateral total hip and right knee arthroplasty in a sickle cell disease patient with multiple joint osteonecrosis: a case report and literature review. Niger Postgrad Med J 31(4), 341–345. [Google Scholar]
  22. Agbeko O, Abena KA, Lartey SQ (2025) Clinical and Radiological Severity of Avascular Necrosis of the Femoral Head in Sickle Cell Disease Patients. J West Afr Coll Surg 15(3), 329–334. [Google Scholar]
  23. Onyemaechi NOC, Enweani UN, Maduka CO (2011) Musculoskeletal complications of sickle cell disease in Enugu, Nigeria. Niger J Med 20(4), 456–461. [Google Scholar]
  24. Lombardo MDM, Maffulli N, Bassani R, et al. (2020) Bilateral THA in the same sitting for avascular necrosis of the head of the femur in sickle cell patient: our African experience. J Biol Regul Homeost Agents 34(4 Suppl. 3), 111-114. [Google Scholar]
  25. Manfroni F, Maffulli N, Lombardo MDM, et al. (2020) One-stage bilateral total hip arthroplasty in a patient with sickle cell disease and previous Girdlestone procedure on the right side: First presentation in Togo. J Biol Regul Homeost Agents 34(4 Suppl. 3), 171-174. [Google Scholar]
  26. Akinyoola AL, Adediran IA, Asaleye CM (2007) Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J 14(3), 217–220. [Google Scholar]
  27. Knox-Macaulay HH (1983) Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults. Ann Trop Med Parasitol 77(4), 411–419. [Google Scholar]
  28. Bokolombe AA, Samato F, Lukinu T, Ekila MB, Aloni MN (2013) Tardive hip disease diagnosis in a young adult with sickle cell disease. Afr Health Sci, 13(1), 171–173. [Google Scholar]
  29. Alonge TO, Shokunbi WA (2004) The choice of arthroplasty for secondary osteoarthritis of the hip joint following avascular necrosis of the femoral head in sicklers. J Natl Med Assoc 96(5), 678–681. [Google Scholar]
  30. Akakpo-Numado GK, Gnassingbe K, Sakiye KA, Boume MA, Amadou A, Tekou H (2008) Aseptic osteonecrosis of the femoral head in children with sickle-cell disease. Sante Montrouge Fr 18(4), 231–233. [Google Scholar]
  31. Mouba JF, Mimbila M, Lentombo LE, Thardin JF, Ondo A (2011) Avascular necrosis of the femoral head in children with sickle cell disease (Libreville, Gabon). Sante Montrouge Fr 21(2), 89–92. [Google Scholar]
  32. Bennis FZ, Biaz A, Zkik A, et al. (2020) Femoral bone infarction revealing compound heterozygous SC sickle cell disease in a Moroccan patient. Pan Afr Med J 36, 361. [Google Scholar]
  33. N’Dri K, Ahoure AM, Zunon-Kipre E, et al. (2000) Appearance on X-ray and computed tomography of femoral head necrosis in patients with sickle cell disease, Sante Montrouge Fr 10(1), 27–30. [Google Scholar]
  34. Akinyoola AL, Adediran IA, Asaleye CM, Bolarinwa AR (2009) Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease, Int Orthop 33(4), 923–926. [Google Scholar]
  35. Ouederni M, Rouag H, Ben Fraj I, et al. (2023) Incidence and risk factors for osteonecrosis of the femoral head in five hundred and ten sickle cell disease paediatric patients. Int Orthop 47(12), 2941–2952. [Google Scholar]
  36. Wu H, Liang Y, Hernigou P (2005) Treatment ischemic necrosis of the femoral head with vascularized iliac graft in young patients with sickle-cell disease. Chin J Reparative Reconstr Surg 19(9), 717–720. [Google Scholar]
  37. Ebong WW (1977) Avascular necrosis of the femoral head associated with haemoglobinopathy. Trop Geogr Med 29(1), 19–23. [Google Scholar]
  38. Sene M, Dansoko A, Ndiaye A, Mbaye E, Niang CD, Faye M (2009) Total hip arthroplasty after avascular necrosis due to sickle cell disease in Senegal: series of 48 replacements. Med Trop Rev Corps Sante Colon, 69(6), 573–576. [Google Scholar]
  39. Ndugwa CM (1992) Aseptic necrosis of the head of the femur among sickle cell anaemia patients in Uganda. East Afr Med J 69(10), 572–576. [Google Scholar]
  40. Ofakunrin AO, Okpe ES, Afolaranmi TO, et al. (2021) Avascular necrosis in children with sickle cell disease: prevalence and pattern of presentation in Jos. Nigeria, Highland Med Res J 21, 51‑56. [Google Scholar]
  41. Bahebeck J, Atangana R, Techa A, Monny-Lobe M, Sosso M, Hoffmeyer P (2004) Relative rates and features of musculoskeletal complications in adult sicklers. Acta Orthop Belg 70(2), 107–111. [Google Scholar]
  42. Mosaku SK, Oyekunle AA, Aneke JC, Bolarinwa RA, Osho PO, Akinola NO (2015) Avascular necrosis significantly impairs quality of life in sickle cell disease. J Clin Sci 12(1), 41-47. [Google Scholar]
  43. Alabi I, Salihu M, Arojuraye S, et al. (2021) Functional outcome of total hip arthroplasty in teenagers with end stage avascular necrosis of the head of femur resulting from sickle cell disease. J Orthop Rheum 5(1), 93-97. [Google Scholar]
  44. Bamgbade OA, Onongaya V, Anomneze-Collins A, Omoniyi DA, Simmonds-Brooks P, Richards RN (2021) Delayed surgical diagnosis and treatment of severe sickle cell arthropathy: The need to raise clinicians’ awareness. J Taibah Univ Med Sci 16(5), 683–688. [Google Scholar]
  45. Lawal Y, Maitama M, Ejagwulu F, Dahiru L, Nattawa M, Lawal A (2017) Bipolar hemiarthroplasty for stage III sickle cell-related avascular necrosis of the femoral head: a successful alternative to total hip replacement. SA Orthop J 16(3), 31-34. [Google Scholar]
  46. Golding JS, Maciver JE, Went LN (1959) The bone changes in sickle cell anaemia and its genetic variants. J Bone Joint Surg Br 41-B, 711–718. [Google Scholar]
  47. Carayon A, Doury P, Pattin S, Zimmer C (1971) Osteo-articular manifestations in drepanocytemia. Ann Med Interne 122(3), 419–426. [Google Scholar]
  48. Barton CJ, Cockshott WP (1962) Bone changes in hemoglobin SC disease. Am J Roentgenol Radium Ther Nucl Med 88, 523–532. [Google Scholar]
  49. Axelrod AR, Clifford GO, Tanaka KR (1956) Sickle cell anemia (homozygous S) with aseptic necrosis of femoral head. Blood 11(11), 998–1008. [Google Scholar]
  50. Chung SMK, Alavi A, Russell MO (1978) Management of osteonecrosis in sickle-cell anemia and its genetic variants. Clin Orthop Relat Res 130, 158-174. [Google Scholar]
  51. Daltro GC, Fortuna V, de Souza ES, et al. (2015) Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Res Ther 6(1), 110. [Google Scholar]
  52. Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, Malaise M, Ino J, Beguin Y (2020) Did osteoblastic cell therapy improve the prognosis of pre-fracture osteonecrosis of the femoral head? A randomized, controlled trial. Clin Orthop Relat Res 478(6), 1307-1315. [Google Scholar]
  53. Neumayr LD, Aguilar C, Earles AN, et al. (2006) Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am 88(12), 2573–2582. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.